Combination Therapy with Thalidomide, Incadronate, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Overview of attention for article published in International Journal of Hematology, October 2005

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 15,521 followers.

RT @Myeloma_Doc: Small study of thalidomide, incadronate & dexamethasone for relapsed/refractory #myeloma shows 33% response rate: https://…

Small study of thalidomide, incadronate & dexamethasone for relapsed/refractory #myeloma shows 33% response rate: https://t.co/CHBA46pFkO. https://t.co/LyQ4pirtLC